7U0

4-(2-azanylethoxy)-N2,N6-bis[4-(2-pyrrolidin-1-ylethoxy)quinolin-2-yl]pyridine-2,6-dicarboxamide

Created:	2022-03-01
Last modified:	2022-06-08

Find Related PDB Entry
1 entries where 7U0 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	96
Chiral Atom Count	0
Bond Count	102
Aromatic Bond Count	28

2D diagram of 7U0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-(2-azanylethoxy)-N2,N6-bis[4-(2-pyrrolidin-1-ylethoxy)quinolin-2-yl]pyridine-2,6-dicarboxamide
Systematic Name (OpenEye OEToolkits)	4-(2-azanylethoxy)-~{N}2,~{N}6-bis[4-(2-pyrrolidin-1-ylethoxy)quinolin-2-yl]pyridine-2,6-dicarboxamide
Formula	C₃₉ H₄₄ N₈ O₅
Molecular Weight	704.817
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	NCCOc1cc(nc(c1)C(=O)Nc2cc(OCCN3CCCC3)c4ccccc4n2)C(=O)Nc5cc(OCCN6CCCC6)c7ccccc7n5
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)c(cc(n2)NC(=O)c3cc(cc(n3)C(=O)Nc4cc(c5ccccc5n4)OCCN6CCCC6)OCCN)OCCN7CCCC7
Canonical SMILES	CACTVS	3.385	NCCOc1cc(nc(c1)C(=O)Nc2cc(OCCN3CCCC3)c4ccccc4n2)C(=O)Nc5cc(OCCN6CCCC6)c7ccccc7n5
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)c(cc(n2)NC(=O)c3cc(cc(n3)C(=O)Nc4cc(c5ccccc5n4)OCCN6CCCC6)OCCN)OCCN7CCCC7
InChI	InChI	1.03	InChI=1S/C39H44N8O5/c40-13-20-50-27-23-32(38(48)44-36-25-34(28-9-1-3-11-30(28)42-36)51-21-18-46-14-5-6-15-46)41-33(24-27)39(49)45-37-26-35(29-10-2-4-12-31(29)43-37)52-22-19-47-16-7-8-17-47/h1-4,9-12,23-26H,5-8,13-22,40H2,(H,42,44,48)(H,43,45,49)
InChIKey	InChI	1.03	ZNJSVFXFCLLIKA-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	46891626

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.